Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 71-80 of 859

Better education needed to stop errors in drip fluid care and prevent potential patient harm, says NICE
In new guidance, NICE is calling on doctors and nurses across England and Wales to become better educated in how to safely care for patients who are given fluids through a drip (intravenous fluid therapy).
December 10, 2013

NICE recommends new treatment option for multiple sclerosis
In final draft guidance the National Institute for Health and Care Excellence (NICE) has recommended the use of Genzyme?s multiple sclerosis drug teriflunomide (also called Aubagio).
December 6, 2013

NICE seeks more information on treatment for potentially serious liver condition
The National Institute for Health and Care Excellence (NICE) is calling on the pharmaceutical company Norgine to provide more information on its drug rifaximin (also called Xifaxan) to treat a brain disease caused by liver failure.
November 27, 2013

NICE says procedure to heal open abdominal wounds is safe after initiating national research
NICE has upgraded its guidance on negative pressure wound therapy - a procedure to help hospitals heal people left with open wounds in their abdomen - after previous guidance, which was issued in 2009, kick-started a national audit of the use of the technique after safety concerns were raised by a specialist unit.
November 27, 2013

NICE gives green light to ranibizumab for eye condition in final guidance
NICE has issued final guidance recommending ranibizumab (Lucentis, Novartis) as a treatment option for sight problems caused by choroidal neovascularisation (CNV) in people with a rare form of short-sightedness known as pathological myopia.
November 27, 2013

NICE's 300th technology appraisal guidance recommends drugs to treat chronic hepatitis C in children and young people
In its 300th technology appraisal guidance NICE has recommended peginterferon alfa in combination with ribavirin as an option for treating chronic hepatitis C in children and young people.
November 27, 2013

NICE says hospitals have a duty of care to help all patients who smoke to quit
NICE, the health and social care guidance body, says in new guidance that all NHS hospitals and clinics should become completely smoke-free to help all patients who smoke, including those receiving mental health treatment, to stop smoking whilst they receive care, and preferably help them to stop for good.
November 27, 2013

NICE to guide the NHS on safe staffing levels
The National Institute for Health and Care Excellence is to give the National Health Service guidance on setting safe staffing levels.
November 19, 2013

New draft standard from NICE aims to raise the bar in the care and support of people experiencing sickle cell crises
The National Institute for Health and Care Excellence (NICE) has issued draft standards that aim to improve the care and management of people presenting to hospital with sickle cell crises. Sickle cell is one of the most commonly inherited serious genetic diseases in England.
November 19, 2013

NICE publishes draft good practice guidance on managing medicines in care homes
NICE publishes draft good practice guidance on managing medicines in care homes
November 18, 2013

This page was last updated: 23 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.